NICE approves CDF drugs for routine NHS use
The National Institute for Health and Care Excellence (NICE) issued final guidance recommending two drugs for routine use within the NHS: Bosutinib (Bosulif, Pfizer) and Pemetrexed (Alimta, Eli Lilly).
Click on this link for more information.
